New: the shifts that come back across the latest research. See what to focus on

Horizon: now

Drug researchers adopt AI but struggle to expand

Drug companies are bringing AI into research, but scattered data and unprepared teams prevent wider use and leave paperwork burdens.

In the report's words: “Biopharma is moving AI into drug research, but disconnected data and unprepared teams hinder expansion.”p66

The number that matters

22%p52

Respondents prepared to access and connect research data

Where to focus

  1. 1Connect research records across systems and standardize formatsp64
  2. 2Train research teams and establish human oversightp57
  3. 3Reduce manual data gathering and regulatory report writingp31

The details

Who it affects

R&D, data, and technology leaders at mid-sized and large biopharma companies with revenue above $500 million.p6

What holds them back

  • Data leaders struggle to connect research data for AI because records sit in separate systems and incompatible formats.p64
  • R&D leaders struggle to expand AI use because teams lack operational readiness and need training and human oversight.p57
  • Regulatory teams struggle to prepare submissions efficiently because compiling data and writing reports involves substantial manual work.p31

The numbers

  • Only 22% say their organization is prepared on data accessibility and integration.p52
  • Among organizations using AI for regulatory documents, 37% report productivity gains, averaging 19% time savings.p48

What people search for

  • connect lab and clinical data for AI
  • clean research data for AI
  • AI training for pharma research teams
  • automate clinical study report writing
  • speed up regulatory submission paperwork